project id: TCGA-ESCA; case submitter id: TCGA-IG-A50L; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.47; rna integrity number: 7.5; age at index: 58; days to birth: -21214; ethnicity: not hispanic or latino; gender: male; race: asian; vital status: Alive; year of birth: 1954; age at diagnosis: 21214; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 16.0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: not reported; alcohol history: No; cigarettes per day: 1.6986301369863013; pack years smoked: 31.0; is ffpe: false; composition: Not Reported; days to collection: 81; days to sample procurement: 0; initial weight: 1210.0; portion submitter id: TCGA-IG-A50L-01A-11; percent lymphocyte infiltration: 3.0; percent monocyte infiltration: 2.0; percent necrosis: 15.0; percent neutrophil infiltration: 4.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;